A detailed history of Nilsine Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Nilsine Partners, LLC holds 70,496 shares of NVO stock, worth $10.1 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
70,496
Previous 71,426 1.3%
Holding current value
$10.1 Million
Previous $7.39 Billion 22.5%
% of portfolio
1.24%
Previous 1.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$102.11 - $135.92 $94,962 - $126,405
-930 Reduced 1.3%
70,496 $9.05 Billion
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $163,270 - $196,137
-1,860 Reduced 2.54%
71,426 $7.39 Billion
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $3.38 Million - $7.41 Million
37,127 Added 102.68%
73,286 $6.66 Billion
Q2 2023

Jul 21, 2023

BUY
$155.98 - $172.65 $130,087 - $143,990
834 Added 2.36%
36,159 $5.85 Billion
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $4.67 Million - $5.62 Million
35,325 New
35,325 $5.62 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.